Shockwave Medical
  • Technology
    • Challenges of Calcium
    • Intravascular Lithotripsy (IVL)
    • IVL Mechanism of Action
  • Clinicians
    • USA
    • Peripheral
      reimbursement Peripheral Reimbursement
      • Pre-TAVI
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • reimbursement Peripheral Reimbursement
    • Coronary
      reimbursement Coronary Reimbursement
    • reimbursement Coronary Reimbursement
    • Transfemoral Access
      • Pre-TAVR
      • Pre-EVAR/TEVAR
    • International
    • Peripheral
      • Pre-TAVR
      • Pre-EVAR
      • Iliac
      • Common Femoral
      • Femoropopliteal
      • Infrapopliteal
      • Clinical Evidence
        • PAD I
        • PAD II
        • PAD III
        • BTK
      • PAD Case Library
      • Product Specs & Resources
        • Shockwave M5
    • Coronary
      • CAD Case Library
      • Clinical Evidence
        • CAD I
        • CAD II
        • CAD III
      • Product Specs & Resources
        • Shockwave C2
    • Transfemoral Access
      • Pre-TAVI
      • Pre-EVAR/TEVAR
  • Education
    • Calcium IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary IVL Reimbursement
  • Investors
    • Overview
    • Stock Information
    • News & Events
    • Financial Information
    • Corporate Governance
    • Investor Resources
  • About
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Home Education Blog
catalyst_logo

Welcome to The Catalyst

Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.

ico email Connect

Equality: Coronary IVL Outcomes by Sex

In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI,...

Read More

Real World, Real Calcium & Real Durability with IVL

It’s no exaggeration that calcium represents the Achilles heel of endovascular treatment. As the...

Read More

SCAI 2022: New Practice-Changing IVL Data

In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta,...

Read More

Vascular News Dives Into the Pluses Behind Shockwave M5+

The presence of calcium can pose significant challenges in achieving optimal procedural outcomes in...

Read More

EuroPCR 2022: We’re back to crack…in person!

After two long years, EuroPCR is finally live again! We can’t wait to meet you in Paris and discuss...

Read More

MEN vs WOMEN in PCI Outcomes: What’s the Consensus?

Some of us know the data. Some don’t. The question once you do is where we go from here to bridge...

Read More

The Consistency of Coronary IVL Across Calcium Types, Genders and Over Time

Discover our PCR webinar featuring European calcium experts, Prof Emanuele Barbato, Prof Javier...

Read More

European Insights on IVL Effectiveness in Eccentric and Nodular Calcium

Prof. Javier Escaned, Hospital Universitario Clínico San Carlos, Madrid, and Prof. James Spratt, St...

Read More

Image-Guided Calcium Modification with Dr. Kevin Croce

Dr. Kevin Croce, Director of Chronic Total Occlusion (CTO)/Complex PCI Program, Interventional...

Read More

Best Practice in Intravascular Lithotripsy

Dr. Benjamin Honton, Interventional Cardiologist at Clinique Pasteur, Toulouse, France, together...

Read More
1 2 3 4 5 ... 12 Next >
Topics
  • CAD Applications - Bifurcations
  • CAD Applications - Eccentric Lesions
  • Calcium Corner
  • ChalkTalk Podcast
  • Clinical Corner with Dr. Keith Dawkins
  • Clinical Corner with SW
  • Coronary Cases
  • Coronary Clinical Data
  • Coronary Conferences
  • Coronary IVL
  • Coronary IVL - U.S.
  • DISRUPT CAD
  • DISRUPT PAD
  • Insider
  • IVL Case
  • IVL Technology
  • Medical Meetings
  • PAD Applications - BTK
  • PAD Applications - CLI
  • PAD Applications - EVAR
  • PAD Applications - Iliac
  • PAD Applications - TAVR Access
  • PAD Applications - TEVAR
  • Peripheral Cases
  • Peripheral Clinical Data
  • Peripheral Conferences
  • Peripheral IVL
  • PulsePoint Newsletter
  • Q&A with Uday
  • Shockwave Behind-the-Scenes
  • Shockwave Breaking News
  • Shockwave C2
  • Shockwave M5
  • Shockwave S4
  • ShockwaveM5+
  • SWAV News

Equality: Coronary IVL Outcomes by Sex

Posted by Michelle Revell on May 18, 2022 4:00:00 PM
  • Tweet

In episode #9 of the ChalkTalk podcast, we speak with Alexandra Lansky, MD, FACC, FAHA, FSCAI, FESC, Professor of Medicine in Cardiology, and Director of Yale Cardiovascular Clinical Research Program at Yale University School of Medicine in New Haven, Connecticut, about her recent gender analyses at TCT21 and SCAI22, in which she presented the respective 30-day and 1-year outcomes broken out by women vs men that were enrolled in the Disrupt CAD clinical program.

 

Dr. Lansky shares the genesis of the analysis - previous research showing that female atherectomy patients have an increased risk for angiographic complications than their male counterparts,[i] and sheds light on what makes coronary IVL unique from a safety perspective. She concludes by discussing the recent publication of SCAI’s “Expert Consensus Statement on Sex-Specific Consideration in Myocardial Revascularization” in JSCAI, which referenced the role of IVL in female patients. The SCAI guidelines concluded, “while additional evidence is needed, these results taken in the context of outcomes with atherectomy devices suggest that IVL may emerge as a first-line therapy for plaque modification of calcified lesions in women specifically.”

 

We hope you enjoy the episode and for more information on coronary IVL in women, please visit TimeForAnIntervention.com.

 

 

 

[i] https://onlinelibrary.wiley.com/doi/10.1002/ccd.28373

Read More
0 Comments Click here to read/write comments

Topics: Shockwave Behind-the-Scenes, Coronary IVL, Shockwave Breaking News, IVL Technology, Coronary Cases, Coronary Clinical Data, Shockwave C2, Coronary Conferences, Coronary IVL - U.S., ChalkTalk Podcast

Real World, Real Calcium & Real Durability with IVL

Posted by Emma Miller on May 17, 2022 1:16:53 AM
  • Tweet

It’s no exaggeration that calcium represents the Achilles heel of endovascular treatment. As the patient population continues to evolve in complexity we need solutions that can treat severe calcified disease in an efficacious, safe and durable way. Listen as Dr Konstantinos Stavroulakis shares the outcomes of his recent publication of Intravascular Lithotripsy (IVL) and DCB in severely calcified femoropopliteal lesions followed out to 12 months and understand why he believes IVL is a game changer in the treatment of complex real world patients.

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, Peripheral Cases, Peripheral Clinical Data

SCAI 2022: New Practice-Changing IVL Data

Posted by Michelle Revell on May 3, 2022 5:28:59 PM
  • Tweet

In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta, Georgia, where SCAI 2022 is taking place this year. At the conference, leading calcium experts will share the 1-year results from the Randomized Disrupt PAD III Trial and 1-year sex specific outcomes with Coronary IVL. 

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, Peripheral IVL, Shockwave Breaking News, IVL Technology, DISRUPT PAD, Coronary Cases, Peripheral Cases, PAD Applications - BTK, Peripheral Conferences, SWAV News, Shockwave C2, Coronary Conferences, Shockwave M5, Shockwave S4, PAD Applications - TEVAR, Coronary IVL - U.S., ShockwaveM5+

Vascular News Dives Into the Pluses Behind Shockwave M5+

Posted by Emma Miller on Apr 25, 2022 5:48:01 PM
  • Tweet

The presence of calcium can pose significant challenges in achieving optimal procedural outcomes in PAD treatment and can pose as a barrier to the delivery of large bore access devices. Shockwave IVL is shifting the paradigm in the way physicians approach calcium by simplifying procedures in an efficacious and safe manner. Now the next generation of peripheral IVL technology is here: Shockwave M5+! The Shockwave M5+ extends treatment options with the introduction of its new features; faster pulsing, an extended working length and expanded size matrix. 

Read More
0 Comments Click here to read/write comments

Topics: Peripheral IVL, Peripheral Cases, Peripheral Clinical Data

EuroPCR 2022: We’re back to crack…in person!

Posted by Emma Miller on Apr 14, 2022 12:20:10 PM
  • Tweet

After two long years, EuroPCR is finally live again! We can’t wait to meet you in Paris and discuss the latest on IVL.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

MEN vs WOMEN in PCI Outcomes: What’s the Consensus?

Posted by Emma Miller on Apr 4, 2022 10:34:01 AM
  • Tweet

Some of us know the data. Some don’t. The question once you do is where we go from here to bridge the gender inequality gap?

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

The Consistency of Coronary IVL Across Calcium Types, Genders and Over Time

Posted by Emma Miller on Mar 28, 2022 12:50:07 PM
  • Tweet

Discover our PCR webinar featuring European calcium experts, Prof Emanuele Barbato, Prof Javier Escaned, Dr Margaret McEntegart, and Prof Flavio Luciano Ribichini discussing about the most recent OCT data analysis from Disrupt CAD Trials.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

European Insights on IVL Effectiveness in Eccentric and Nodular Calcium

Posted by Emma Miller on Mar 25, 2022 2:20:00 PM
  • Tweet

Prof. Javier Escaned, Hospital Universitario Clínico San Carlos, Madrid, and Prof. James Spratt, St George’s University Hospital NHS Trust, London, discussed with Cardiovascular News their views about the latest data from the pooled analysis of 262 patients enrolled in OCT sub-studies from Disrupt CAD I, II, III, & IV.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

Image-Guided Calcium Modification with Dr. Kevin Croce

Posted by Emma Miller on Mar 22, 2022 4:21:38 PM
  • Tweet

Dr. Kevin Croce, Director of Chronic Total Occlusion (CTO)/Complex PCI Program, Interventional Cardiologist, Brigham and Women’s Hospital, Assistant Professor of Medicine, Harvard Medical School, Boston Massachusetts talks about the importance of image guided plaque modification in optimizing PCI, discusses the role of IVL in calcium modification and share his insights on Coronary IVL in different calcium morphologies.

 

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, Coronary Cases, Shockwave C2, Coronary IVL - U.S., Calcium Corner

Best Practice in Intravascular Lithotripsy

Posted by Emma Miller on Mar 22, 2022 3:58:27 PM
  • Tweet

Dr. Benjamin Honton, Interventional Cardiologist at Clinique Pasteur, Toulouse, France, together with Dr. Jacques Monsegu, Groupe Hospitalier Mutualiste de Grenoble, France, write about best practices for IVL use in the cath lab based on his 3 years of experience with the technology. In this review you will find IVL technical, scientific and clinical overview, such as lesion selection with focus on concentric and eccentric calcification, analysis of specific clinical indications and some useful tips for crossing and therapy delivery.

Read More
0 Comments Click here to read/write comments

Topics: Coronary IVL, IVL Case, IVL Technology, Coronary Cases, Shockwave C2, Coronary IVL - U.S.

All posts Next

We're excited about IVL's potential in aortic stenosis, too!

But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.

MORE ON TAVR ENABLING TRANSFEMORAL ACCESS
SIGN UP FOR UPDATES ON OUR VALVE R&D PROGRAM

Get Crackin with Shockwave IVL Today

To keep you apprised of the latest IVL news, education, and cases, please share your selected interests.

Shockwave Medical

Corporate Headquarters
5403 Betsy Ross Drive
Santa Clara, CA 95054
United States

1-877-77-LITHO (775-4846)

info@shockwavemedical.com

  • Technology
    • Challenges of Calcium
  • Applications
    • US
    • Peripheral
    • Coronary
    • TF Access
    • International
    • Peripheral
    • Coronary
    • TF Access
  • Education
    • Ca++ IVLeague
    • The Catalyst
  • Resources
    • IFU Portal
    • Peripheral Reimbursement
    • Coronary Reimbursement
  • Investors
  • About Us
    • Our Story
    • People
    • Careers
    • Patents
    • Press Releases
    • Contact
Follow us

Prior to use, please reference the Instructions for Use for more information on indications, contraindications, warnings, precautions and adverse events.

  • Privacy Policy
  • ISI
  • Patents

© 2022 Shockwave Medical Inc. All rights reserved. | SPL 63081 Rev. A